JPH09225032A - Syringe - Google Patents

Syringe

Info

Publication number
JPH09225032A
JPH09225032A JP8025752A JP2575296A JPH09225032A JP H09225032 A JPH09225032 A JP H09225032A JP 8025752 A JP8025752 A JP 8025752A JP 2575296 A JP2575296 A JP 2575296A JP H09225032 A JPH09225032 A JP H09225032A
Authority
JP
Japan
Prior art keywords
outer cylinder
injection
plug
syringe
injection port
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8025752A
Other languages
Japanese (ja)
Inventor
Keinosuke Isono
啓之介 磯野
Kazuya Araki
和也 荒木
Hiroshi Motobayashi
博志 本林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Material Engineering Technology Laboratory Inc
Original Assignee
Material Engineering Technology Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Material Engineering Technology Laboratory Inc filed Critical Material Engineering Technology Laboratory Inc
Priority to JP8025752A priority Critical patent/JPH09225032A/en
Publication of JPH09225032A publication Critical patent/JPH09225032A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/284Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M2005/1787Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • A61M2005/3132Syringe barrels having flow passages for injection agents at the distal end of the barrel to bypass a sealing stopper after its displacement to this end due to internal pressure increase

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a syringe previously filled with a liquid, which enables highly simplifying of the molding of an outer cylinder while sufficiently securing safety for handling, contamination and the like during injection along with safe operation. SOLUTION: An outer cylinder 2 is a molded product made of a thermoplastic resin and a plug body 5 is provided on the side of a gasket 4 spaced at an interval from an injection port 2A. A ridge rib 11 extending almost in the axial direction of the outer cylinder 2 is formed on an internal wall of the outer cylinder part between the plug body 5 and the injection port 2A. In the course of movement of the plug body to the injection port 2A, an outer circumferential wall of the plug body 5 is elastically deformed by the ridge rib 11 to form a clearance so that an injection agent 6 passes to the injection port. The ridge rib 11 formed at the position between the plug body 5 and the injection port 2A provides a space part at least with the width thereof exceeding 2mm during the formation of the clearance.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、予め注射剤が充填され
た注射器に関するものであり、より詳細には、外筒の射
出成形が簡単で、注射剤を外筒内に液密に充填して滅菌
処理が簡単にでき、また異なる注射成分が無菌的に充填
され、注射に際して各注射成分が順次無菌的に体内に投
与される二成分用注射器に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a syringe pre-filled with an injection agent. More specifically, the injection method of the outer cylinder is simple, and the injection agent is liquid-tightly filled in the outer cylinder. The present invention relates to a two-component syringe in which sterilization can be easily performed, different injection components are aseptically filled, and each injection component is sequentially and aseptically administered into the body upon injection.

【0002】[0002]

【従来の技術】最近、医療事故を未然に防止するため
に、また院内感染等を極力防止するために、予め滅菌又
は無菌状態で外筒内に薬剤又は薬液等の注射剤が充填さ
れたプレフィールドシリンジと一般に称される注射器が
提案されている。また、かかるプレフィールドシリンジ
には二医薬成分以上の注射剤がその注射時まで分離して
充填されている多成分用注射器も提案されている。
2. Description of the Related Art In recent years, in order to prevent medical accidents and to prevent hospital-acquired infections and the like as much as possible, sterile or aseptic pre-filled syringes have been filled with injections such as drugs or medicinal solutions. Syringes, commonly referred to as field syringes, have been proposed. In addition, a multi-component syringe in which an injection of two or more pharmaceutical ingredients is separately filled in the prefield syringe until the injection is also proposed.

【0003】従来、このような注射器には、先端部に注
射針が取り付けられる射出口を有した外筒及びガスケッ
トを有したプランジャー以外に、上記外筒内の先端奥部
に配せられ上記射出口を塞ぐ栓体を有し、その栓体とガ
スケットとの間に注射液が液密充填されたものが提案さ
れている(実開平2−51560号公報)。このような
注射器では所定量の注射液がほぼ満杯(充填室にエア等
の侵入が殆どない状態)に外筒に液密に充填することが
できる。また、蒸気滅菌等も極めて容易であり、滅菌時
にガスケットをある程度、摺動可能とすれば、充填室内
に圧もかからない状態でスムーズに滅菌できる方法等が
採用できる(特開平5−253296号公報、特開平5
−305140号公報)。
Conventionally, in such an injector, in addition to an outer cylinder having an injection port to which an injection needle is attached at the tip and a plunger having a gasket, the syringe is disposed at the inner end of the tip in the outer cylinder. There is proposed a plug having a plug for closing the injection port, and an injection liquid is liquid-tightly filled between the plug and the gasket (Japanese Utility Model Publication No. 2-51560). In such a syringe, the outer cylinder can be liquid-tightly filled with a predetermined amount of the injection liquid almost completely (a state in which air or the like hardly enters the filling chamber). Further, steam sterilization and the like are extremely easy, and if the gasket can be slid to some extent during sterilization, a method such as smooth sterilization without pressure in the filling chamber can be adopted (JP-A-5-253296, JP-A-5
-305140).

【0004】また、多成分用注射器は、上述の目的から
栓体と射出口との間の外筒内壁面を窪ませて、かかる窪
みを注射成分同士が混ざるバイパス路として形成してい
る。図13は、従来の二液成分用注射器の断面図であ
る。図13に示す如く注射器70は、ガスケットを有し
たプランジャー71と、外筒72からなり、外筒72は
ガラス又はプラスチック成形物である。外筒72の内壁
面には窪み部73(又は内径の膨張部)が軸方向に形成
され、窪み部73は摺動栓体74と射出口75との間に
ある。また、第一成分と第二成分との異なる注射剤7
6、77は栓体74を境に無菌充填され、射出口75に
はキャップ78が被せられている。
For the above-mentioned purpose, the multi-component injector has a hollow inner wall surface between the stopper and the injection port, and the hollow is formed as a bypass passage for mixing the injection components. FIG. 13 is a sectional view of a conventional two-component syringe. As shown in FIG. 13, the syringe 70 includes a plunger 71 having a gasket and an outer cylinder 72, and the outer cylinder 72 is a glass or plastic molded product. A hollow portion 73 (or an expanded portion of the inner diameter) is formed on the inner wall surface of the outer cylinder 72 in the axial direction, and the hollow portion 73 is between the sliding plug body 74 and the injection port 75. In addition, an injectable drug 7 different from the first component and the second component 7
6 and 77 are aseptically filled with the stopper 74 as a boundary, and the injection port 75 is covered with a cap 78.

【0005】このような構成の注射器70にあっては、
プランジャー71を押し込むと、栓体74は移動させら
れ、窪み部73に位置する。このため、基端側の注射剤
77は、図13(B)に示す如くプランジャー71の更
なる押し込みにより窪み部73から先端部側に流入し注
射剤76と混ざる。従って、注射剤76、77は使用時
に外筒72内で無菌的に混合されて必要とされる注射剤
として提供される。また、注射器の製造時、注射剤7
6、77は高圧蒸気滅菌などがなされる。この場合に、
滅菌時にガスケットをある程度、摺動可能とすれば、充
填室内に圧もかからない状態でスムーズに滅菌できる方
法等が採用できる(特開平5−253296号公報、特
開平5−305140号公報)。
In the syringe 70 having such a structure,
When the plunger 71 is pushed in, the stopper 74 is moved and positioned in the recess 73. Therefore, the injection agent 77 on the proximal end side flows into the distal end portion side from the recessed portion 73 by the further pushing of the plunger 71 as shown in FIG. Therefore, the injections 76 and 77 are aseptically mixed in the outer cylinder 72 at the time of use and provided as required injections. In addition, when manufacturing a syringe,
Nos. 6 and 77 are subjected to high-pressure steam sterilization. In this case,
If the gasket can be slid to some extent during sterilization, it is possible to adopt a method that can be smoothly sterilized without applying pressure to the filling chamber (JP-A-5-253296 and JP-A-5-305140).

【0006】[0006]

【発明が解決しようとする課題】しかしながら、従来の
注射器では、注射時に射出口と充填室とを連通させるた
めに、両端に刺針部を有する両端刺型注射針が使用され
る。かかる注射針は射出口の装着時に外筒内の栓体を一
旦刺針するため、注射針の取扱に対する耐汚染性が失わ
れるおそれがある。また注射時の現場で注射針の装着手
続が必要となるため、操作上の汚染に対する安全性も低
める。また、従来の注射器に使用される外筒は、高価な
ガラス製の外筒であるが、かかる外筒はプラスチック製
のものと異なり、成形が容易でなく、使用後の消却処理
に手間がかかるという問題がある。
However, in the conventional syringe, a double-ended pricking injection needle having a pricking portion at both ends is used in order to make the injection port and the filling chamber communicate with each other at the time of injection. Since such an injection needle punctures the stopper inside the outer cylinder once when the injection port is attached, there is a risk that the contamination resistance against handling of the injection needle may be lost. In addition, since it is necessary to attach the injection needle at the injection site, the safety against contamination during operation is reduced. Further, the outer cylinder used in the conventional syringe is an expensive glass outer cylinder, but unlike the outer cylinder made of plastic, it is not easy to mold and it takes time to dispose of it after use. There is a problem.

【0007】更に、従来の二液成分用注射器では種々の
問題がある。第一に、外筒の成形に問題がある。外筒に
は窪み部73が形成されるが、かかる窪み部の形成は、
ガラス製、及びプラスチック製を問わず成形を困難にし
ている。特に、使い捨て用の注射器として便利なプラス
チック製注射器では、窪み部73からの型抜きが困難な
ため歩留まりを十分に得るほどの射出成形ができない。
第二に、外筒の先端側の注射剤76を高圧蒸気滅菌する
場合に問題がある。基端側の注射剤77の滅菌ではガス
ケットを滅菌時にある程度、摺動可能とすれば問題はな
いが、先端部の注射剤76の滅菌では、栓体74を摺動
可能に置くことはできない。このため、外筒の先端部内
は滅菌時に高圧となり、ガラス製外筒では弱い口部を破
損するおそれがあり、プラスチック製では圧と熱により
膨張して塑性変形するおそれがある。特に、従来の二液
成分用注射器では、基端側の注射剤77を注射前に一旦
先端側外筒内に完全に流入させるため、注射剤76の先
端側外筒内に空隙を必要とし、空隙内のエアは上記問題
を助長する。第三に、従来の二液成分用注射器では、注
射時に注射剤同士を混合することを前提に設計された
が、後述する本願発明のような新たな二液成分用注射器
では、注射時に混合しないで注射するものが望まれてい
る。このため、従来の注射器70では、先ず先端側の注
射剤76を体内に注射し、次に基端側の注射剤77を注
射することができない。例えば痛みを伴う注射剤77を
投与する場合、注射剤76と注射剤77とが混ざってし
まうため、注射剤76に局部麻酔薬剤を使用して注射局
部の痛みを和らげた後、次に痛みを伴う注射剤77を無
菌的に注射することができない。また、本出願の発明者
等は、外筒の射出口の近傍に開放操作可能な栓体を有す
るものを種々提案してきた。このような注射器ではその
操作時に栓体が開放されたとき、プランジャーの過剰な
押し込みが生じることが分かった。このため、かかる過
剰な押し込みにより、外筒内の注射剤が射出口から飛び
出す不具合が生じた。
Further, the conventional two-component syringe has various problems. First, there is a problem in molding the outer cylinder. A hollow portion 73 is formed on the outer cylinder. The formation of the hollow portion is
Molding is difficult regardless of whether it is made of glass or plastic. In particular, with a plastic syringe that is convenient as a disposable syringe, it is difficult to perform die-cutting from the recessed portion 73, and therefore injection molding cannot be performed to obtain a sufficient yield.
Secondly, there is a problem in high-pressure steam sterilization of the injection agent 76 on the tip side of the outer cylinder. The sterilization of the injection agent 77 on the proximal side does not cause any problem if the gasket can be slid to some extent during sterilization, but the sterilization of the injection agent 76 on the distal end cannot place the stopper 74 slidably. For this reason, the inside of the tip portion of the outer cylinder has a high pressure during sterilization, and a weak mouth portion may be damaged in the glass outer cylinder, and plastic material may be expanded and plastically deformed by pressure and heat. In particular, in the conventional two-liquid component injector, since the injection agent 77 on the proximal end side is allowed to completely flow into the distal end side external cylinder before injection, a space is required in the distal end side external cylinder of the injection agent 76, Air in the air gaps promotes the above problems. Third, the conventional two-component syringe was designed on the premise that the injections are mixed with each other at the time of injection, but a new two-component syringe like the invention of the present application described later does not mix at the time of injection. What to inject in is desired. Therefore, in the conventional syringe 70, it is impossible to first inject the injection agent 76 on the distal end side into the body and then inject the injection agent 77 on the proximal end side. For example, when administering an injectable agent 77 with pain, the injectable agent 76 and the injectable agent 77 are mixed with each other. Therefore, a local anesthetic is used for the injectable agent 76 to relieve the local pain of the injection and then The accompanying injection 77 cannot be aseptically injected. In addition, the inventors of the present application have proposed various types of plugs that can be opened in the vicinity of the injection port of the outer cylinder. It has been found that in such a syringe, when the plug is opened during its operation, excessive pushing of the plunger occurs. Therefore, due to such excessive pushing, there is a problem that the injection agent in the outer cylinder jumps out from the injection port.

【0008】従って、本発明の目的は、外筒の成形が極
めて簡単にできると共に、注射時の取扱や汚染等に対す
る安全性が十分に確保され、且つその操作が安全になさ
れる予め液充填された注射器を提供することにある。本
発明の目的はまた、高圧蒸気滅菌に対しても外筒が極め
て高い耐熱変形強度を有し、二成分の注射剤の滅菌が確
実になされ、注射時に二成分の注射剤を混合させずに順
次無菌的に投与できる予め液充填された二液成分用注射
器を提供することにある。
Therefore, it is an object of the present invention that the outer cylinder can be molded very easily, the safety against handling and contamination during injection is sufficiently ensured, and the operation is made safe by prefilling with liquid. To provide a syringe. The object of the present invention is also that the outer cylinder has extremely high heat distortion resistance against high-pressure steam sterilization, ensures sterilization of the two-component injection, and does not mix the two-component injection during injection. It is an object of the present invention to provide a pre-liquid-filled two-component syringe that can be sequentially and aseptically administered.

【0009】[0009]

【課題を解決するための手段】本発明は、先端部に注射
針が取り付けられる射出口を有した外筒と、ガスケット
が取り付けられて上記外筒に挿入されるプランジャーと
からなり、また上記外筒内の先端奥部に栓体を配して上
記射出口を塞ぎ該栓体とガスケットとの間に注射剤が液
密充填される注射器において、上記外筒は熱可塑性樹脂
の成形物であり、上記栓体は、上記射出口から一定間隔
あけて上記ガスケット側に設けられ、上記栓体と射出口
との間の上記外筒部分の内側壁には、上記外筒のほぼ軸
方向に延びる凸条リブが形成され、上記栓体が射出口ま
で移動する途中で、上記凸条リブにより上記栓体の外周
壁が弾性変形して上記注射剤が射出口に流通する空隙が
形成され、且つ該空隙形成時の上記栓体と上記射出口と
の間の位置には少なくとも幅(S)が2mm以上の空間
部を有するように上記凸条リブが形成されていることを
特徴とする注射器を提供することにより、上記目的を達
成したものである。
SUMMARY OF THE INVENTION The present invention comprises an outer cylinder having an injection port to which an injection needle is attached at the tip, and a plunger attached with a gasket and inserted into the outer cylinder. In a syringe in which a plug is arranged in the inner part of the tip of the outer cylinder to close the injection port and the injection is liquid-tightly filled between the plug and the gasket, the outer cylinder is a molded product of a thermoplastic resin. The plug body is provided on the gasket side at a constant distance from the injection port, and the inner wall of the outer cylinder portion between the plug body and the injection port is provided in a substantially axial direction of the outer cylinder. An extended ridge rib is formed, and while the plug is moving to the injection port, the ridge rib elastically deforms the outer peripheral wall of the plug to form a space for the injection to flow into the injection port, Moreover, the position between the plug body and the injection port at the time of forming the void is small. By Kutomo width (S) to provide a syringe which is characterized in that the ridge ribs are formed so as to have a space of more than 2 mm, it is obtained by achieving the above object.

【0010】本発明にかかる注射器において、上記空間
部の幅(S)は上記ガスケット及び栓体の合計幅以下で
あることを特徴とする。本発明にかかる注射器におい
て、上記外筒内の上記ガスケット及び栓体との間に仕切
り栓体が設けられ、該仕切り栓体を境にそれぞれ異なる
成分の注射剤が充填され、上記空間部の幅(S)は上記
ガスケット、栓体及び仕切り栓体の合計幅以下であるこ
とを特徴とする注射器を提供することにより、上記第二
の目的を達成したものである。
In the syringe according to the present invention, the width (S) of the space is less than or equal to the total width of the gasket and the plug. In the syringe according to the present invention, a partition plug body is provided between the gasket and the plug body in the outer cylinder, and the partition plug body is filled with injection agents of different components, and the width of the space portion. (S) achieves the second object by providing a syringe characterized by having a total width of the gasket, the stopper and the partition stopper which is equal to or less than the total width.

【0011】[0011]

【作用】上記注射器は、例えば図1に示す如く、外筒の
射出口付近に栓体が配され、栓体とプランジャーのガス
ケットとの間には注射剤が無菌的に収容されている。ま
た、栓体と射出口との間の外筒内壁面には凸状リブが形
成されている。このため、その操作時、プランジャーが
押し込まれると、これに連動して栓体が射出口側に押し
込まれる。押し込まれた栓体の外周壁には上記凸状リブ
が食い込み、栓体の外周壁が変形する。栓体の外周壁の
変形により、栓体の外周壁と外筒の内壁との間に空隙が
形成され、栓体とガスケットとの間の注射剤が空隙を介
して射出口側に流入する。プランジャーはその摺動時に
ガスケット及び栓体の動摩擦抵抗及び凸状リブの乗り上
げ抵抗を受け、栓体の外周壁と外筒の内壁との間に空隙
が形成されたとき、栓体の動摩擦抵抗及び凸状リブの乗
り上げ抵抗がなくなる。このため、栓体の外周壁と外筒
の内壁とに空隙を生じた瞬間、プランジャーの操作上、
過剰押し込みが生じる。従って、かかる過剰押し込みに
より、ガスケットと栓体との間の注射剤はその空隙を通
って射出口側に急激に流入し、装着した針先から注射剤
が飛び出すおそれが生じる。しかし、上記注射器にあっ
ては、栓体の外周壁と外筒の内壁との間に空隙が形成さ
れたとき、栓体と射出口との間の位置には少なくとも幅
(s)が2mm以上の空間部を有するように凸状リブが
形成されているため、急激に流入する注射剤はかかる空
間部にストックされ、装着した針先から注射剤が飛び出
すというおそれがない。
In the syringe, as shown in FIG. 1, for example, a plug is arranged near the injection port of the outer cylinder, and the injection is aseptically contained between the plug and the gasket of the plunger. Further, a convex rib is formed on the inner wall surface of the outer cylinder between the plug body and the injection port. Therefore, when the plunger is pushed in at the time of the operation, the plug body is pushed toward the ejection port side in conjunction with this. The convex rib bites into the outer peripheral wall of the pushed plug body, and the outer peripheral wall of the plug body is deformed. Due to the deformation of the outer peripheral wall of the stopper, a gap is formed between the outer peripheral wall of the stopper and the inner wall of the outer cylinder, and the injection agent between the stopper and the gasket flows into the injection port side through the gap. When the plunger slides, it receives the dynamic friction resistance of the gasket and the plug body and the riding resistance of the convex rib, and when a gap is formed between the outer peripheral wall of the plug body and the inner wall of the outer cylinder, the dynamic friction resistance of the plug body. Also, the riding resistance of the convex rib is eliminated. Therefore, at the moment when a gap is created between the outer peripheral wall of the stopper and the inner wall of the outer cylinder, in operation of the plunger,
Excessive indentation occurs. Therefore, due to such excessive pushing, the injection agent between the gasket and the stopper may suddenly flow into the injection port side through the gap, and the injection agent may fly out from the attached needle tip. However, in the above syringe, when a gap is formed between the outer peripheral wall of the stopper and the inner wall of the outer cylinder, at least the width (s) is 2 mm or more at the position between the stopper and the injection port. Since the convex rib is formed so as to have the space portion, the injectable agent that rapidly flows in is stocked in the space portion, and there is no fear that the injectable agent will fly out from the attached needle tip.

【0012】また注射器は、その製造時に外筒は簡単に
射出成形される。即ち、樹脂成形物である外筒を射出成
形する場合、外筒の先端内壁に形成される凸条リブを容
易に形成することができる。凸条リブは軸方向に形成さ
れ外筒の先端奥部に向かうものであるため、射出成形時
の型外しが容易にできる。更に、凸条リブが先端奥部に
向かって徐々に頂部が隆起してテーパ状に形成される
と、外筒成形物は型外し時の歪み等の影響を受け難い。
また上記注射器の組立に際しては、外筒内に先ず栓体を
挿入し、注射剤を充填し、ガスケットを嵌めて高圧蒸気
滅菌を行う。尚、注射針は一般的なものが用いられ予め
外筒の射出口に取り付けて蒸気滅菌をしても良い。従っ
て、注射剤の高圧蒸気滅菌は簡単になされ、両端刺型注
射針等を取り付ける場合と相違して、通常の注射針を既
に外筒に滅菌装着しておくことができる。
The outer cylinder of the syringe is easily injection-molded at the time of manufacture. That is, when the outer cylinder, which is a resin molded product, is injection-molded, the ribs formed on the inner wall at the tip of the outer cylinder can be easily formed. Since the ribs are formed in the axial direction and extend toward the inner part of the distal end of the outer cylinder, the mold can be easily removed during injection molding. Furthermore, when the convex ribs are formed so that the tops gradually rise toward the inner part of the tip and are formed in a taper shape, the outer cylinder molded product is less susceptible to distortion and the like at the time of mold release.
When assembling the above-mentioned syringe, the stopper is first inserted into the outer cylinder, the injection is filled, and the gasket is fitted to perform high-pressure steam sterilization. A general injection needle is used and may be attached to the injection port of the outer cylinder in advance for steam sterilization. Therefore, high-pressure steam sterilization of the injection is easily performed, and unlike the case where a double-ended stick type injection needle or the like is attached, a normal injection needle can be already sterilized and attached to the outer cylinder.

【0013】[0013]

【実施例】以下、本発明に係る注射器の好ましい実施例
を添付図面を参照しながら詳述する。図1は本発明の注
射器の第一実施例の側断面図、図2は図1のI−I線に
沿った注射器の断面図、図3は図1の注射器のプランジ
ャーを途中まで押し込んだ状態を示す側断面図、図4は
図3のII−II線に沿った注射器の断面図、図5は第
一実施例の注射器に用いられる栓体の側面図、図6は図
3に於ける栓体部分の側断面図、図7はプランジャーを
完全に押し込んだときの第一実施例の側断面図、図8は
第一実施例における注射器の外筒の先端の肩部内壁面を
示した斜視図である。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Preferred embodiments of a syringe according to the present invention will be described below in detail with reference to the accompanying drawings. FIG. 1 is a side sectional view of a first embodiment of the syringe of the present invention, FIG. 2 is a sectional view of the syringe taken along the line I-I of FIG. 1, and FIG. 3 is a partially pushed plunger of the syringe of FIG. FIG. 4 is a side sectional view showing a state, FIG. 4 is a sectional view of the syringe taken along line II-II of FIG. 3, FIG. 5 is a side view of a stopper used in the syringe of the first embodiment, and FIG. 6 is FIG. Fig. 7 is a side sectional view of the stopper body portion, Fig. 7 is a side sectional view of the first embodiment when the plunger is completely pushed in, and Fig. 8 is a shoulder inner wall surface of the tip of the outer cylinder of the syringe in the first embodiment. FIG.

【0014】図1〜図8に示す第一実施例の注射器1
は、先端部に注射針7が取り付けられる射出口2Aを有
した外筒2と、ガスケット4が取り付けられて外筒2に
嵌入されるプランジャー3とからなり、また外筒2内の
先端奥部に栓体5を配して射出口2Aを塞ぎ栓体5とガ
スケット4との間に注射剤6が液密充填されている。注
射器1の外筒2は熱可塑性樹脂の成形物であり、栓体5
は、射出口2Aから一定間隔あけてガスケット4側に設
けられ、栓体5と射出口2Aとの間の外筒2部分の内側
壁には、外筒2の軸方向に延びる凸条リブ11、11・
・・が形成され、栓体5が射出口2Aに達する際に、凸
条リブ11、11・・・により栓体5の外周壁が弾性変
形して注射剤6が射出口2Aに流通する空隙が形成され
る。また、空隙形成時の栓体5と射出口2Aとの間の位
置には少なくとも幅(S)が2mm以上、ガスケット4
及び栓体5の合計幅以下である空間部99を有するよう
に凸条リブ11、11・・が形成されている。
The syringe 1 of the first embodiment shown in FIGS.
Is composed of an outer cylinder 2 having an injection port 2A to which an injection needle 7 is attached at the tip, and a plunger 3 fitted with a gasket 4 and fitted into the outer cylinder 2. The injection body 6 is liquid-tightly filled between the plug body 5 and the gasket 4 by disposing the plug body 5 in the portion to close the injection port 2A. The outer cylinder 2 of the syringe 1 is a molded product of thermoplastic resin, and has a plug 5
Is provided on the gasket 4 side at a constant distance from the injection port 2A, and on the inner wall of the outer cylinder 2 portion between the plug body 5 and the injection port 2A, a ridge rib 11 extending in the axial direction of the outer cylinder 2 is provided. , 11 ...
··························································································································································································································································································· [ Is formed. Further, at least a width (S) of 2 mm or more is provided at a position between the plug body 5 and the injection port 2A when forming the gap, and the gasket 4 is provided.
The ribs 11, 11 ... Are formed so as to have a space 99 that is less than or equal to the total width of the plug 5.

【0015】本実施例の注射器1を更に説明すると、本
実施例の注射器1の外筒2は、熱可塑性樹脂の成形物
で、射出成形により成形される。外筒2に凸条リブ11
を形成するため、このようなプラスチック筒であること
が好ましい。使用されるプラスチック材としては、例え
ば、低密度或は高密度ポリエチレン、ポリプロピレン、
ポリブタジエン−1等のポリオレフィン類、ポリ塩化ビ
ニル、ポリ塩化ビニリデン、塩化ビニリデン共重合体、
ポリメタクリル酸メチル、ポリビニルアルコール、エチ
レン−ビニルアルコール共重合体、アクリロニトリル共
重合体、ポリエチレンテレフタレート等を挙げることが
できる。特に、ポリオレフィン類は汎用性及び薬剤に影
響を与えない点で好ましく、更には非晶質の環状のオレ
フィンコポリマー等の高いガラス転移温度を有し比重が
1.0〜1.1のものが望ましい。具体的には、光デイ
スク基板、光学レンズなどの材料として最近用いられて
いる商標名ゼオネックス(日本ゼオン株式会社)、商標
名アペル(三井石油化学工業株式会社)等のポリオレフ
ィン系樹脂である。
To further explain the syringe 1 of this embodiment, the outer cylinder 2 of the syringe 1 of this embodiment is a molded product of a thermoplastic resin and is formed by injection molding. Convex ribs 11 on the outer cylinder 2
Such a plastic cylinder is preferable for forming Examples of the plastic material used include low density or high density polyethylene, polypropylene,
Polyolefins such as polybutadiene-1, polyvinyl chloride, polyvinylidene chloride, vinylidene chloride copolymer,
Examples thereof include polymethyl methacrylate, polyvinyl alcohol, ethylene-vinyl alcohol copolymer, acrylonitrile copolymer and polyethylene terephthalate. In particular, polyolefins are preferable from the viewpoint of versatility and chemicals, and those having a high glass transition temperature such as an amorphous cyclic olefin copolymer and a specific gravity of 1.0 to 1.1 are desirable. . Specifically, it is a polyolefin resin such as a trade name Zeonex (Nippon Zeon Co., Ltd.) and a trade name Apel (Mitsui Petrochemical Industry Co., Ltd.), which are recently used as materials for optical disk substrates, optical lenses and the like.

【0016】ガスケット4及び栓体5は外筒2の内壁と
液密を保つ程度の弾性体を有するものであれば良い。具
体的にはゴム製のガスケット及びゴム栓が用いられる。
図1及び図2に示す如く栓体5は、射出口2Aから一定
間隔あけてガスケット4側に設けられ、ガスケット4と
栓体5との間の外筒2内には注射剤6が滅菌状態で充填
される。滅菌は高圧蒸気滅菌がなされており、これ以外
にも無菌充填などが可能であるが、滅菌を確実にするに
は高圧蒸気滅菌が望ましい。
The gasket 4 and the plug 5 may be any as long as they have an elastic body that maintains liquid tightness with the inner wall of the outer cylinder 2. Specifically, a rubber gasket and a rubber stopper are used.
As shown in FIGS. 1 and 2, the plug body 5 is provided on the gasket 4 side with a certain distance from the injection port 2A, and the injection agent 6 is sterilized in the outer cylinder 2 between the gasket 4 and the plug body 5. Filled with. High-pressure steam sterilization is performed for sterilization, and aseptic filling can be performed in addition to this, but high-pressure steam sterilization is desirable to ensure sterilization.

【0017】栓体5と射出口2Aとの間の外筒2の内壁
面には、複数の凸条リブ11が外筒2の軸方向に向かっ
て形成される。即ち、凸条リブ11は外筒2の成形時の
型抜き方向とほぼ同一の方向に向けて形成される。ま
た、凸条リブ11の数は、1以上、好ましくは3以上、
更に好ましく5以上である。また凸条リブ11が複数形
成される場合は、点対称の配置がなされても良いし、ま
た外筒2の一部の内壁面に偏らせて形成しても良い。ま
た凸条リブ11は外筒2の先端奥部に向かって徐々に隆
起したテーパ頂部11Aとなっている。テーパは必ずし
も必要ではない。しかし、かかるテーパ頂部11Aの形
成は、成形の型抜き時に型などの影響を受けず、スムー
スに型を抜くことができ、また、注射器1の使用時に栓
体5が外筒2の奥深くスムースに挿入することができ
る。
A plurality of convex ribs 11 are formed on the inner wall surface of the outer cylinder 2 between the stopper 5 and the injection port 2A in the axial direction of the outer cylinder 2. That is, the ribs 11 are formed in a direction substantially the same as the die cutting direction when the outer cylinder 2 is molded. The number of the ribs 11 is 1 or more, preferably 3 or more,
It is more preferably 5 or more. When a plurality of convex ribs 11 are formed, they may be arranged symmetrically with respect to each other, or may be formed so as to be biased to a part of the inner wall surface of the outer cylinder 2. Further, the convex rib 11 is a tapered top portion 11A that gradually rises toward the inner end of the outer cylinder 2. The taper is not always necessary. However, the formation of the tapered top portion 11A allows the die to be smoothly removed without being affected by the die or the like during the die removal of the molding, and the plug body 5 can be smoothly inserted deep into the outer cylinder 2 when the syringe 1 is used. Can be inserted.

【0018】外筒2の内径(L)は12mmであり、図
5に示す如く栓体5は外筒2内を液密に摺動するため、
栓体5の周条弾性リブ部5A、5Aの径は内壁外筒2の
内径より若干太めに形成されている。凸条リブ11は一
定間隔を置いて12本形成される。また、凸条リブ頂部
11Aの最大高さ(w)は1mmである。凸条リブ頂部
11Aの最大高さ(w)は、外筒の内径(L)によって
好ましい範囲が決定され、凸条リブ頂部11Aの最大高
さ(w)が外筒の内径(L)の1/50〜1/5倍であ
ることが好ましい。凸条リブ頂部11Aの最大高さ
(w)が上記範囲を下回ると、外筒2の外周壁と栓体5
の内周壁との間に充分な空隙12ができないおそれがあ
り、上記範囲を上回ると、栓体5の摺動性が悪くなる。
The inner diameter (L) of the outer cylinder 2 is 12 mm, and the plug 5 slides in the outer cylinder 2 in a liquid-tight manner as shown in FIG.
The diameters of the peripheral elastic rib portions 5A, 5A of the plug body 5 are formed to be slightly thicker than the inner diameter of the inner wall outer cylinder 2. Twelve convex ribs 11 are formed at regular intervals. Further, the maximum height (w) of the convex rib top portion 11A is 1 mm. A preferable range of the maximum height (w) of the convex rib tops 11A is determined by the inner diameter (L) of the outer cylinder, and the maximum height (w) of the convex rib tops 11A is 1 of the inner diameter (L) of the outer cylinder. It is preferably / 50 to 1/5 times. When the maximum height (w) of the convex rib top portion 11A is less than the above range, the outer peripheral wall of the outer cylinder 2 and the plug body 5 are separated.
There is a possibility that a sufficient space 12 cannot be formed between the inner peripheral wall of the plug and the inner wall of the plug.

【0019】また凸条リブ11の形成位置は、栓体5が
弾性変形して栓体5の外周壁と外筒2の内壁とに空隙が
形成される位置により決定される。即ち、図3に示す如
く栓体5が射出口2Aまで移動する途中で空隙が形成さ
れ、その空隙の形成時の栓体と射出口との間が少なくと
も2mm以上の幅(S)の空間部99が存在するように
凸条リブ11が形成される。空隙部99の幅(S)は2
mm以上、特に4mm以上、ガスケット3及び栓体5の
合計幅以下であることが望ましい。空隙部99の幅
(S)が上記範囲より下回れば過剰流入してくる注射剤
の貯留が十分にできない。上記範囲を上回れば図7の状
態で凸条リブ11によりガスケット4からの液漏れが生
じるおそれがある。
The position where the ribs 11 are formed is determined by the position where the plug 5 is elastically deformed and a gap is formed between the outer peripheral wall of the plug 5 and the inner wall of the outer cylinder 2. That is, as shown in FIG. 3, a gap is formed during the movement of the plug body 5 to the ejection port 2A, and a space portion having a width (S) of at least 2 mm or more between the plug body and the ejection port when the gap is formed. The ridge rib 11 is formed so that 99 exists. The width (S) of the void 99 is 2
It is desirable that the width is not less than mm, particularly not less than 4 mm and not more than the total width of the gasket 3 and the plug 5. If the width (S) of the void 99 is less than the above range, the excessive inflow of the injection cannot be stored. If the amount exceeds the above range, liquid leakage from the gasket 4 may occur due to the ribs 11 in the state of FIG. 7.

【0020】図8に示す如く、本実施例の外筒2の射出
口2Aが形成される肩部13の内壁には、複数の突起部
14が形成され、突起部14により、外筒2の内側壁と
栓体5の外周壁との空隙12を流れる注射剤6を射出口
2Aに導くための通路15、15が形成される。かかる
通路15は、必ずしも必要はないが、栓体5が完全に肩
部13の内周面に密着して注射剤6の流出通路が塞がれ
るのを防止している。従って、突起部14を形成する代
わりに、肩部13の内壁面に溝状部を形成して射出口2
Aまでの通路を確保しても良い。
As shown in FIG. 8, a plurality of protrusions 14 are formed on the inner wall of the shoulder 13 in which the injection port 2A of the outer cylinder 2 of this embodiment is formed. Passages 15, 15 are formed for guiding the injection 6 flowing through the space 12 between the inner wall and the outer wall of the plug 5 to the injection port 2A. The passage 15 is not necessarily required, but prevents the plug 5 from completely adhering to the inner peripheral surface of the shoulder 13 and blocking the outflow passage of the injection 6. Therefore, instead of forming the projecting portion 14, a groove-like portion is formed on the inner wall surface of the shoulder portion 13 to form the injection port 2
You may secure the passage to A.

【0021】次に、上記注射器1の製造方法を説明する
と、先ず、射出成形により外筒2と共に凸条リブ11、
及び突起部14を正確に形成する。この場合、凸条リブ
11が外筒2の軸方向でしかもテーパ状に形成されるた
め、外筒2を歪ませることなく正確に型抜き成形でき、
特に、上述の非晶質のポリオレフィンにおいて正確な成
形ができる。注射剤6が外筒2に充填され、充填後、外
筒2にガスケット4を取り付ける。更にプランジャー3
をガスケット4に取り付け、注射針7を射出口2Aに取
り付ける。その後、かかる状態で、注射器1を高圧蒸気
滅菌して注射剤6を滅菌する。尚、プランジャー3及び
注射針7は、高圧蒸気滅菌後に無菌的に取り付けても良
い。
Next, a method of manufacturing the above-mentioned syringe 1 will be described. First, the ribs 11, the ribs 11, and the outer tube 2 are formed by injection molding.
And the protrusion 14 is accurately formed. In this case, since the ribs 11 are formed in a taper shape in the axial direction of the outer cylinder 2, the outer cylinder 2 can be accurately die-molded without being distorted.
In particular, accurate molding can be performed with the above-mentioned amorphous polyolefin. The injection 6 is filled in the outer cylinder 2, and after the filling, the gasket 4 is attached to the outer cylinder 2. Plunger 3
Is attached to the gasket 4, and the injection needle 7 is attached to the injection port 2A. Then, in this state, the syringe 1 is sterilized by high-pressure steam to sterilize the injection 6. The plunger 3 and the injection needle 7 may be aseptically attached after high-pressure steam sterilization.

【0022】次に、本実施例の注射器1を用いて注射す
る場合は、図1の注射器の状態から図3に示す如くプラ
ンジャー3が押し込まれると、これに連動して栓体5が
射出口2A側に押し込まれる。図4及び6に示す如く栓
体5の外周壁には凸状リブ11が食い込み、栓体5の外
周壁が変形する。栓体5の外周壁の変形により、栓体5
の外周壁と外筒2の内壁との間に空隙12が形成され、
栓体5とガスケット4との間の注射剤7が空隙12を介
して射出口2A側に流入する。プランジャー3はその摺
動時にガスケット4及び栓体5の動摩擦抵抗及び凸状リ
ブの乗り上げ抵抗を受け、栓体5の外周壁と外筒2の内
壁との間に空隙12が形成されたとき、栓体5は停止し
栓体5の動摩擦抵抗及び凸状リブ11の乗り上げ抵抗が
なくなる。このため、栓体5の外周壁と外筒2の内壁と
に空隙12を生じた瞬間、プランジャー3の操作上、過
剰押し込みが生じる。従って、かかる過剰押し込みによ
り、ガスケット4と栓体5との間の注射剤6はその空隙
12を通って射出口2A側に急激に流入し、装着した針
先7から注射剤6が飛び出すおそれが生じる。
Next, in the case of injecting using the syringe 1 of this embodiment, when the plunger 3 is pushed in from the state of the syringe of FIG. 1 as shown in FIG. 3, the plug 5 is fired in conjunction with this. It is pushed to the exit 2A side. As shown in FIGS. 4 and 6, the convex ribs 11 bite into the outer peripheral wall of the plug 5 to deform the outer peripheral wall of the plug 5. Due to the deformation of the outer peripheral wall of the stopper 5,
A space 12 is formed between the outer peripheral wall of the outer cylinder and the inner wall of the outer cylinder 2,
The injection agent 7 between the stopper 5 and the gasket 4 flows into the injection port 2A side through the space 12. When the plunger 3 receives the dynamic frictional resistance of the gasket 4 and the plug 5 and the riding resistance of the convex rib during sliding, a gap 12 is formed between the outer peripheral wall of the plug 5 and the inner wall of the outer cylinder 2. The stopper 5 stops, and the dynamic frictional resistance of the stopper 5 and the riding resistance of the convex rib 11 disappear. Therefore, at the moment when the gap 12 is formed between the outer peripheral wall of the plug body 5 and the inner wall of the outer cylinder 2, excessive pushing occurs due to the operation of the plunger 3. Therefore, due to such excessive pushing, the injection 6 between the gasket 4 and the stopper 5 may suddenly flow into the injection port 2A side through the gap 12, and the injection 6 may fly out from the attached needle tip 7. Occurs.

【0023】しかし、注射器1では、栓体5の外周壁と
外筒2の内壁との間に空隙12が形成されたとき、栓体
5と射出口2Aとの間の位置には少なくとも幅(s)が
2mm以上の空間部99を有するように凸状リブ11が
形成されているため、急激に流入する注射剤6はかかる
空間部99にストックされ、装着した針7先から注射剤
6が飛び出すというおそれがない。次に、かかる状態
で、外筒2、射出口2A及び注射針7内のエアを追い出
した後、注射針を患者に刺針する。そして、プランジャ
ー3を更に押し込み、栓体5を完全に外筒2の奥まで摺
動させて図7に示す如く注射処理を完了する。従って、
注射器1は滅菌処理などが極めて容易となり、また注射
器1に両端刺型の注射針を用いないため、注射器1には
予め注射針を取り付けることができ、作業現場での汚染
事故を少なくすることができる。尚、上記実施例では、
栓体5は液密用の周条弾性リブ5Aを2つ有している
が、液密性が保持される限り、このような周条弾性リブ
5Aを有していなくても良い。
However, in the syringe 1, when the gap 12 is formed between the outer peripheral wall of the stopper 5 and the inner wall of the outer tube 2, at least the width () is provided at a position between the stopper 5 and the injection port 2A. Since the convex rib 11 is formed so that s) has the space 99 of 2 mm or more, the injectable solution 6 that rapidly flows in is stocked in the space 99 and the injection 6 is injected from the tip of the attached needle 7. There is no fear of jumping out. Next, in this state, the air in the outer cylinder 2, the ejection port 2A and the injection needle 7 is expelled, and then the injection needle is punctured into the patient. Then, the plunger 3 is further pushed in and the stopper 5 is slid completely into the outer cylinder 2 to complete the injection process as shown in FIG. Therefore,
The syringe 1 is extremely easy to be sterilized, and since the double-ended needle is not used for the syringe 1, it is possible to attach the injection needle to the syringe 1 in advance, and it is possible to reduce contamination accidents at the work site. it can. In the above embodiment,
Although the plug 5 has two liquid-tight circumferential elastic ribs 5A, such a circumferential elastic rib 5A may not be provided as long as the liquid-tightness is maintained.

【0024】次に、図9乃至図12に従って本発明の第
二実施例の注射器について説明する。 図8は本発明の
注射器の第二実施例の側断面図である。図10〜12は
第二実施例の注射器を使用する工程を示す断面図であ
る。図9〜図12に示す第二実施例の二液成分用注射器
21は、先端部に注射針7が取り付けられる射出口2A
を有した外筒2と、ガスケット4が取り付けられて外筒
2に嵌入されるプランジャー3とからなり、また外筒2
内の先端奥部に栓体5を配して射出口2Aを塞ぎ栓体5
とガスケット4との間に注射剤6A、6Bが液密充填さ
れている点で、第一実施例の注射器1とほぼ同様な部材
及び構造なので、かかる部材については第一実施例の注
射器1と同一の符号を賦してその詳しい説明を省略す
る。また、注射器21の外筒2は熱可塑性樹脂の成形物
であり、栓体5は、射出口2Aから一定間隔あけてガス
ケット4側に設けられ、栓体5と射出口2Aとの間の外
筒2部分の内側壁には、外筒2の軸方向に延びる凸条リ
ブ11、11・・・が形成されている点でも、第一実施
例の注射器1とほぼ同様な部材及び構造なので、かかる
部材については第一実施例の注射器1と同一の符号を賦
してその詳しい説明を省略する。
Next, a syringe according to a second embodiment of the present invention will be described with reference to FIGS. FIG. 8 is a side sectional view of the second embodiment of the syringe of the present invention. 10 to 12 are sectional views showing steps of using the syringe of the second embodiment. The two-component syringe 21 of the second embodiment shown in FIGS. 9 to 12 has an injection port 2A to which the injection needle 7 is attached at the tip.
And an outer cylinder 2 having a gasket 4 attached thereto and fitted into the outer cylinder 2.
The plug 5 is arranged in the inner part of the tip end to close the ejection port 2A and the plug 5
Since the injection agents 6A and 6B are liquid-tightly filled between the gasket 4 and the gasket 4, the members and the structure are substantially the same as those of the syringe 1 of the first embodiment. The same reference numerals are given and detailed description thereof is omitted. Further, the outer cylinder 2 of the syringe 21 is a molded product of a thermoplastic resin, and the plug body 5 is provided on the gasket 4 side with a certain distance from the injection port 2A, and is provided outside the space between the plug body 5 and the injection port 2A. Since the ribs 11, 11, ... That extend in the axial direction of the outer cylinder 2 are formed on the inner wall of the cylinder 2 portion, the members and the structure are substantially the same as the syringe 1 of the first embodiment. Such members are given the same reference numerals as those of the syringe 1 of the first embodiment, and detailed description thereof will be omitted.

【0025】注射器21が注射器1と異なる点は、外筒
2内のガスケット4及び栓体5との間に仕切り栓体22
が設けられ、仕切り栓体22を境にそれぞれ異なる成分
の注射剤6A、6Bが充填され、空間部の幅(S)は栓
体5及び仕切り栓体22の幅以上、ガスケット4、栓体
5及び仕切り栓体22の合計幅以下であることである。
The syringe 21 differs from the syringe 1 in that the partition plug 22 is provided between the gasket 4 and the plug 5 in the outer cylinder 2.
Is provided and filled with the injectables 6A and 6B having different components at the partition plug body 22 as a boundary, and the width (S) of the space portion is not less than the widths of the plug body 5 and the partition plug body 22, the gasket 4 and the plug body 5. And the total width of the partition plug body 22 or less.

【0026】本実施例の二液成分用注射器21を更に説
明すると、注射器21の外筒2は、従来より長く成形さ
れる。仕切り栓体22はガスケット4及び栓体5と同様
に外筒2の内壁と液密を保つ程度の弾性を有するもので
あれば良い。具体的にはゴム製のガスケット及びゴム栓
と同様なものが用いられる。栓体5と仕切り栓体22の
間には注射剤6Aが収容され、仕切り栓体22とガスケ
ット4の間には注射剤6Bが収容されている。例えば本
実施例では注射剤6Aは局部麻酔剤等であり、注射剤6
Bは痛みを伴う注射剤である。注射剤6A、6Bの滅菌
は高圧蒸気滅菌がなされており、これ以外にも無菌充填
などが可能であるが、滅菌を確実にするには高圧蒸気滅
菌が望ましい。高圧蒸気滅菌は、温度が105℃〜14
0℃の範囲であるが、特に、温度が105℃〜125℃
の範囲であることが望ましい。かかる範囲であれば、外
筒2に熱・圧による変形が生じ難い。
The two-component syringe 21 of this embodiment will be further described. The outer cylinder 2 of the syringe 21 is formed longer than before. As with the gasket 4 and the plug 5, the partition plug 22 may be elastic enough to maintain liquid tightness with the inner wall of the outer cylinder 2. Specifically, the same material as the rubber gasket and the rubber stopper is used. An injection agent 6A is accommodated between the stopper body 5 and the partition stopper body 22, and an injection agent 6B is accommodated between the partition stopper body 22 and the gasket 4. For example, in this embodiment, the injection 6A is a local anesthetic, etc.
B is a painful injection. High-pressure steam sterilization is performed for sterilization of the injections 6A and 6B, and aseptic filling can be performed in addition to this, but high-pressure steam sterilization is desirable to ensure sterilization. High-pressure steam sterilization has a temperature of 105 ° C to 14 ° C.
The temperature is in the range of 0 ° C, but especially when the temperature is 105 ° C to 125 ° C.
Is desirably within the range. Within such a range, the outer cylinder 2 is unlikely to be deformed by heat and pressure.

【0027】栓体5と射出口2Aとの間の外筒2の内壁
面には、第一実施例の注射器1と同様な長めの複数の凸
条リブ11が外筒2の軸方向に向かって形成されてい
る。また凸条リブ11の形成位置またはその長さは、栓
体5が弾性変形して栓体5の外周壁と外筒2の内壁とに
空隙が形成される位置により決定される。即ち、図10
に示す如く栓体5が射出口2Aまで移動する途中で空隙
が形成され、その空隙の形成時の栓体5と射出口2Aと
の間が少なくとも栓体5幅以上に空間部99が存在する
ように凸条リブ11が形成される。また空間部99の幅
(S)はガスケット3、栓体5及び仕切り栓体22の合
計幅以下であることが望ましい。上記範囲を上回れば図
11に示す状態で凸条リブ11によりガスケット4から
の液漏れが生じるおそれがある。
On the inner wall surface of the outer tube 2 between the plug 5 and the injection port 2A, a plurality of elongated ribs 11 having a length similar to that of the syringe 1 of the first embodiment are directed in the axial direction of the outer tube 2. Is formed. The formation position or the length of the convex rib 11 is determined by the position where the plug 5 is elastically deformed and a gap is formed between the outer peripheral wall of the plug 5 and the inner wall of the outer cylinder 2. That is, FIG.
As shown in FIG. 5, a gap is formed during the movement of the plug 5 to the ejection port 2A, and a space 99 exists at least between the width of the plug 5 and the ejection port 2A when the gap is formed and at least the width of the plug 5 or more. Thus, the ribs 11 are formed. The width (S) of the space 99 is preferably less than or equal to the total width of the gasket 3, the plug body 5, and the partition plug body 22. If it exceeds the above range, there is a possibility that the convex rib 11 causes liquid leakage from the gasket 4 in the state shown in FIG.

【0028】次に、上記注射器1の製造方法を説明する
と、先ず、射出成形により外筒2と共に凸条リブ11、
及び突起部14を正確に形成する。外筒2には栓体5が
所定の深さまで挿入され、注射剤6Aが外筒2内に充填
される。注射剤6Aの充填後、仕切り栓体22が外筒2
内にエアが入らない状態で所定の深さまで挿入される。
次に注射剤6Bが外筒2内に充填され、その充填後、ガ
スケット4が外筒2内にエアが入らない状態で挿入され
る。そして、ガスケット4にプランジャー4が取付ら
れ、射出口2Aにプロテクター付の注射針7が取付けら
れる。かかる状態で、注射器21を高圧蒸気滅菌して注
射剤6A、6Bが滅菌される。
Next, a method of manufacturing the above-mentioned syringe 1 will be described. First, the ridge rib 11 together with the outer cylinder 2 by injection molding,
And the protrusion 14 is accurately formed. The plug 5 is inserted into the outer cylinder 2 to a predetermined depth, and the injection 6A is filled in the outer cylinder 2. After the injection agent 6A is filled, the partition plug body 22 is attached to the outer cylinder 2
It is inserted to a specified depth with no air inside.
Next, the injection 6B is filled in the outer cylinder 2, and after the filling, the gasket 4 is inserted in the outer cylinder 2 in a state where no air enters. Then, the plunger 4 is attached to the gasket 4, and the injection needle 7 with a protector is attached to the injection port 2A. In this state, the syringe 21 is sterilized by high-pressure steam to sterilize the injections 6A and 6B.

【0029】次に、本実施例の二液成分用注射器21を
用いて注射するには、図9の状態からプランジャー3が
押し込まれ、注射剤6A、6Bを介して栓体5及び仕切
り栓体22が図10の位置まで押し込まれる。図10の
位置まで押し込まれると、栓体5の外周壁と外筒2の内
壁との間に空隙が形成され、栓体5はプランジャー3の
押し込みがあっても移動が停止する。従って、注射剤6
Aが一旦急激に空間部99に流入されるが、針先7まで
達することがないため漏れでない。空間部99のエアを
追い出した後、注射剤6Aが患者に注射投与される。図
11の位置まで仕切り栓体22がプランジャー3により
押し込まれると、仕切り栓体22の外周壁と外筒2の内
壁との間に空隙が形成され、仕切り栓体22はプランジ
ャー3の押し込みがあっても移動が停止する。そして、
注射剤6Bが射出口2A側に流入され、プランジャー3
が更に押し込まれ、患者の体内に注射投与される。かか
る投与と共に栓体5は凸条リブ11の部分に移動させら
れ、図3の状態から図4に示す如く栓体5の外周壁と外
筒2の内周壁との間に空隙12が形成される。 従っ
て、先に局部麻酔剤が患者に投与され、痛みを麻痺させ
た状態で、痛みを伴う注射剤6Bを投与することができ
る。
Next, for injection using the two-component syringe 21 of this embodiment, the plunger 3 is pushed in from the state of FIG. 9 and the stopper 5 and the partition stopper are inserted through the injections 6A and 6B. The body 22 is pushed to the position shown in FIG. When pushed to the position shown in FIG. 10, a gap is formed between the outer peripheral wall of the plug 5 and the inner wall of the outer cylinder 2, and the plug 5 stops moving even if the plunger 3 is pushed. Therefore, injection 6
Although A rapidly flows into the space 99 once, it does not leak because it does not reach the needle tip 7. After the air in the space 99 is expelled, the injection 6A is injected and administered to the patient. When the partition plug body 22 is pushed to the position shown in FIG. 11 by the plunger 3, a gap is formed between the outer peripheral wall of the partition plug body 22 and the inner wall of the outer cylinder 2, and the partition plug body 22 is pushed in by the plunger 3. The movement stops even if there is. And
The injection 6B flows into the injection port 2A side, and the plunger 3
Is further pushed and injected into the patient's body. With such administration, the plug body 5 is moved to the portion of the ribs 11, and a gap 12 is formed between the outer peripheral wall of the plug body 5 and the inner peripheral wall of the outer cylinder 2 from the state of FIG. 3 as shown in FIG. It Therefore, the local anesthetic is first administered to the patient, and the painful injection 6B can be administered while the pain is paralyzed.

【0030】[0030]

【発明の効果】以上説明したように本発明の注射器にお
いて、上記外筒は熱可塑性樹脂の成形物であり、上記栓
体は、上記射出口から一定間隔あけて上記ガスケット側
に設けられ、上記栓体と射出口との間の上記外筒部分の
内側壁には、上記外筒のほぼ軸方向に延びる凸条リブが
形成され、上記栓体が射出口まで移動する途中で、上記
凸条リブにより上記栓体の外周壁が弾性変形して上記注
射剤が射出口に流通する空隙が形成され、且つ該空隙形
成時の上記栓体と上記射出口との間の位置には少なくと
も幅(S)が2mm以上の空間部を有するように上記凸
条リブが形成されているので、外筒の成形が極めて簡単
にできると共に、注射時の取扱や汚染等に対する安全性
が十分に確保され、且つその操作が安全になされる。ま
た本発明の注射器において、上記外筒内の上記ガスケッ
ト及び栓体との間に仕切り栓体が設けられ、該仕切り栓
体を境にそれぞれ異なる成分の注射剤が充填され、上記
空間部の幅(S)は上記ガスケット、栓体及び仕切り栓
体の合計幅以下であるので、高圧蒸気滅菌に対しても外
筒が極めて高い耐熱変形強度を有し、二成分の注射剤の
滅菌が確実になされ、注射時に二成分の注射剤を混合さ
せずに順次無菌的に投与できる。
As described above, in the syringe of the present invention, the outer cylinder is a molded product of a thermoplastic resin, and the plug body is provided on the gasket side with a certain distance from the injection port. A ridge rib extending substantially in the axial direction of the outer cylinder is formed on the inner wall of the outer cylinder portion between the plug and the injection port, and the ridge rib is formed while the plug is moving to the injection port. The ribs elastically deform the outer peripheral wall of the plug to form a void for allowing the injection to flow into the injection port, and at least the width (position of between the plug and the injection port at the time of forming the void ( Since the convex ribs are formed so that S) has a space of 2 mm or more, the outer cylinder can be molded very easily, and the safety for handling during injection and contamination is sufficiently ensured. And the operation is done safely. Further, in the injector of the present invention, a partition plug is provided between the gasket and the plug in the outer cylinder, and an injectable agent having different components is filled with the partition plug as a boundary, and the width of the space portion. Since (S) is less than the total width of the gasket, stopper and partition stopper, the outer cylinder has extremely high heat distortion resistance against high pressure steam sterilization, and sterilization of the two-component injection is ensured. That is, the two components can be sequentially and aseptically administered without being mixed at the time of injection.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明に係る注射器の第一実施例の側断面図で
ある。
FIG. 1 is a side sectional view of a first embodiment of a syringe according to the present invention.

【図2】図1におけるI−I線に沿う断面図である。FIG. 2 is a cross-sectional view taken along line I-I in FIG.

【図3】第一実施例の注射器のプランジャーを途中まで
押し込んだ状態を示す断面図である。
FIG. 3 is a cross-sectional view showing a state where the plunger of the syringe of the first embodiment is pushed in halfway.

【図4】図3におけるII−II線に沿う断面図であ
る。
4 is a sectional view taken along the line II-II in FIG.

【図5】第一実施例の注射器に用いられる栓体の側面図
である。
FIG. 5 is a side view of a stopper used in the syringe of the first embodiment.

【図6】図5の栓体が外筒内の凸条リブに押し込まれた
状態を示す断面図である。
FIG. 6 is a cross-sectional view showing a state in which the plug body of FIG. 5 is pushed into a ridge rib inside the outer cylinder.

【図7】第一実施例の注射器のプランジャーを完全に押
し込んだ状態を示す断面図である。
FIG. 7 is a sectional view showing a state where the plunger of the syringe of the first embodiment is completely pushed in.

【図8】第一実施例の注射器の肩部内面の斜視図であ
る。
FIG. 8 is a perspective view of the inner surface of the shoulder portion of the syringe of the first embodiment.

【図9】第二実施例の注射器の側断面図である。FIG. 9 is a side sectional view of the syringe of the second embodiment.

【図10】第二実施例の注射器のプランジャーを途中ま
で押し込んだ状態を示す断面図である。
FIG. 10 is a cross-sectional view showing a state where the plunger of the syringe of the second embodiment is pushed in halfway.

【図11】第二実施例の注射器のプランジャーを途中ま
で押し込んだ状態を示す断面図である。
FIG. 11 is a cross-sectional view showing a state where the plunger of the syringe of the second embodiment is pushed in halfway.

【図12】第二実施例における注射器のプランジャーを
完全に押し込んだ状態を示す断面図である。
FIG. 12 is a sectional view showing a state where the plunger of the syringe in the second embodiment is completely pushed in.

【図13】(A)及び(B)は従来の注射器の側断面図
である。
13A and 13B are side sectional views of a conventional syringe.

【符号の説明】[Explanation of symbols]

1、21 注射器 2 外筒 2A 外筒の射出口 3 プランジャー 4 ガスケット 5 栓体 6 注射剤 7 注射針 11 凸条リブ 22 仕切り栓体 1, 21 Syringe 2 Outer cylinder 2A Outlet of outer cylinder 3 Plunger 4 Gasket 5 Stopper 6 Injection 7 Injection needle 11 Convex rib 22 Partition stopper

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 先端部に注射針が取り付けられる射出口
を有した外筒と、ガスケットが取り付けられて上記外筒
に挿入されるプランジャーとからなり、また上記外筒内
の先端奥部に栓体を配して上記射出口を塞ぎ該栓体とガ
スケットとの間に注射剤が液密充填される注射器におい
て、 上記外筒は熱可塑性樹脂の成形物であり、 上記栓体は、上記射出口から一定間隔あけて上記ガスケ
ット側に設けられ、上記栓体と射出口との間の上記外筒
部分の内側壁には、上記外筒のほぼ軸方向に延びる凸条
リブが形成され、 上記栓体が射出口まで移動する途中で、上記凸条リブに
より上記栓体の外周壁が弾性変形して上記注射剤が射出
口に流通する空隙が形成され、且つ該空隙形成時の上記
栓体と上記射出口との間の位置には少なくとも幅(S)
が2mm以上の空間部を有するように上記凸条リブが形
成されていることを特徴とする注射器。
1. An outer cylinder having an injection port to which an injection needle is attached at the tip, and a plunger attached to the outer cylinder with a gasket attached, and at the inner part of the tip inside the outer cylinder. In a syringe in which a plug is arranged to close the injection port and an injection is liquid-tightly filled between the plug and a gasket, the outer cylinder is a molded product of a thermoplastic resin, and the plug is Provided on the gasket side with a certain distance from the injection port, a ridge rib extending substantially in the axial direction of the outer cylinder is formed on the inner wall of the outer cylinder portion between the plug and the injection port, During the movement of the stopper to the injection port, the outer circumferential wall of the stopper is elastically deformed by the convex ribs to form a space for the injection to flow into the injection port, and the plug at the time of forming the space is formed. At least the width (S) is located between the body and the outlet.
The above-mentioned convex rib is formed so as to have a space of 2 mm or more.
【請求項2】 上記空間部の幅(S)は上記ガスケット
及び栓体の合計幅以下であることを特徴とする請求項1
記載の注射器。
2. The width (S) of the space is less than or equal to the total width of the gasket and the plug body.
The syringe as described.
【請求項3】 上記外筒内の上記ガスケット及び栓体と
の間に仕切り栓体が設けられ、該仕切り栓体を境にそれ
ぞれ異なる成分の注射剤が充填され、 上記空間部の幅(S)は上記ガスケット、栓体及び仕切
り栓体の合計幅以下であることを特徴とする請求項1記
載の注射器。
3. A partition plug body is provided between the gasket and the plug body in the outer cylinder, and injecting agents of different components are filled with the partition plug body as a boundary, and the width of the space (S ) Is less than or equal to the total width of the gasket, stopper and partition stopper, the syringe according to claim 1.
JP8025752A 1995-12-22 1996-01-19 Syringe Pending JPH09225032A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8025752A JPH09225032A (en) 1995-12-22 1996-01-19 Syringe

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35028995 1995-12-22
JP7-350289 1995-12-22
JP8025752A JPH09225032A (en) 1995-12-22 1996-01-19 Syringe

Publications (1)

Publication Number Publication Date
JPH09225032A true JPH09225032A (en) 1997-09-02

Family

ID=26363438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8025752A Pending JPH09225032A (en) 1995-12-22 1996-01-19 Syringe

Country Status (1)

Country Link
JP (1) JPH09225032A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1808192A1 (en) * 2006-01-12 2007-07-18 Nipro Corporation Pre-filled syringe
JP2007533450A (en) * 2004-04-21 2007-11-22 ノードソン コーポレーション Syringe and method of manufacturing a syringe
EP2000163A2 (en) * 2006-02-28 2008-12-10 Hisamitsu Pharmaceutical Co., Inc. Syringe cylinder
JP2009183768A (en) * 1998-03-13 2009-08-20 Becton Dickinson & Co Method for manufacturing, filling and packaging medical containers
JP2010273921A (en) * 2009-05-29 2010-12-09 Yoshino Kogyosho Co Ltd Syringe container
WO2014004695A1 (en) * 2012-06-26 2014-01-03 Glucago, Llc Reconstitution device
US8992469B2 (en) 2012-06-26 2015-03-31 Glucago Llc Reconstitution device
WO2015036992A3 (en) * 2013-09-10 2015-06-11 Augma Biomaterials Ltd. Dual component applicator
US9125995B2 (en) 2012-12-05 2015-09-08 Glucago Llc Reconstitution devices
US9149581B2 (en) 2009-03-09 2015-10-06 Glucago Llc Compact device for rapidly mixing and delivering substances to a patient
CN107454852A (en) * 2015-01-28 2017-12-08 立方制药N·卡乐福列斯公司 For establishing between cavity the apparatus and method connected in Multicarity container

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009183768A (en) * 1998-03-13 2009-08-20 Becton Dickinson & Co Method for manufacturing, filling and packaging medical containers
JP2007533450A (en) * 2004-04-21 2007-11-22 ノードソン コーポレーション Syringe and method of manufacturing a syringe
JP4682850B2 (en) * 2006-01-12 2011-05-11 ニプロ株式会社 Prefilled syringe
JP2007185319A (en) * 2006-01-12 2007-07-26 Nipro Corp Prefilled syringe
EP1808192A1 (en) * 2006-01-12 2007-07-18 Nipro Corporation Pre-filled syringe
US7699811B2 (en) 2006-01-12 2010-04-20 Nipro Corporation Pre-filled syringe
EP2000163A4 (en) * 2006-02-28 2011-11-16 Hisamitsu Pharmaceutical Co Syringe cylinder
EP2000163A2 (en) * 2006-02-28 2008-12-10 Hisamitsu Pharmaceutical Co., Inc. Syringe cylinder
US9149581B2 (en) 2009-03-09 2015-10-06 Glucago Llc Compact device for rapidly mixing and delivering substances to a patient
JP2010273921A (en) * 2009-05-29 2010-12-09 Yoshino Kogyosho Co Ltd Syringe container
WO2014004695A1 (en) * 2012-06-26 2014-01-03 Glucago, Llc Reconstitution device
US8992469B2 (en) 2012-06-26 2015-03-31 Glucago Llc Reconstitution device
US9125995B2 (en) 2012-12-05 2015-09-08 Glucago Llc Reconstitution devices
WO2015036992A3 (en) * 2013-09-10 2015-06-11 Augma Biomaterials Ltd. Dual component applicator
US20160213447A1 (en) * 2013-09-10 2016-07-28 Augma Biomaterials Ltd. Dual component applicator
US10543467B2 (en) 2013-09-10 2020-01-28 Augma Biomaterials Ltd. Dual component applicator
CN107454852A (en) * 2015-01-28 2017-12-08 立方制药N·卡乐福列斯公司 For establishing between cavity the apparatus and method connected in Multicarity container
CN107454852B (en) * 2015-01-28 2020-07-03 立方制药N·卡乐福列斯公司 Apparatus and method for establishing communication between chambers in a multi-chamber container

Similar Documents

Publication Publication Date Title
EP0609741B1 (en) Prefilled syringe assembly
JPH09225029A (en) Injector and its manufacture
RU2428214C2 (en) Ampoule applied as syringe, and syringe comprising ampoule
JPH0412990Y2 (en)
EP1323446B1 (en) Syringe-type container for liquid medicine
JP4682850B2 (en) Prefilled syringe
US20060079848A1 (en) Non-skin penetrating reconstituting syringe
JPH0232898B2 (en)
MXPA00010073A (en) Retracting needle syringe.
JP2001112867A (en) Syringe containing drug
JP4818752B2 (en) Injection molding die for outer cylinder for syringe, manufacturing method for outer cylinder for syringe, outer cylinder for syringe and prefilled syringe
JP2007185319A5 (en)
JPH10295814A (en) Cannula tight sealing shield assembly
WO2015033951A1 (en) Outer tube for syringe and mold for injection molding
JPH09225032A (en) Syringe
JPH08238324A (en) Means for mixed injection of plural medicinal liquids
JPH09628A (en) Syringe for two injection ingredients
US6213980B1 (en) Fill facilitating unit dose injection cartridge and filling method
GB2064964A (en) Syringe
JP2008099728A (en) Syringe serving also as container
JP4144027B2 (en) Two-component prefilled syringe
JP3558742B2 (en) Container / syringe
JP4144026B2 (en) Two-component prefilled syringe
JPH09294808A (en) Injection filling method
JPH1094602A (en) Syringe